Plain-English translation of NCT03001362 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a 'watch-and-wait' approach for patients with rectal cancer who receive radiation therapy combined with chemotherapy as their primary treatment. Instead of automatically having surgery after radiation, this study will monitor patients closely to see if those who have a complete response to the radiation can safely avoid surgery altogether while being carefully watched for any signs of cancer returning.
Surgery after radiation therapy for rectal cancer can cause serious complications, including death in some cases, and may permanently affect bowel, urinary, and sexual function. This trial exists to see whether patients whose tumors completely disappear with radiation alone have similar survival rates and better quality of life if they are monitored carefully instead of undergoing surgery.
You likely qualify if…
You likely don't qualify if…
You would receive radiation therapy at a dose of 54 Gy delivered over 30 treatment sessions, combined with chemotherapy given according to your hospital's standard treatment plan. After completing this treatment, instead of immediately having surgery, you would be carefully monitored with regular imaging and clinical visits to see how your cancer responds and watch for any signs of recurrence. The study will track your outcomes and quality of life over time to determine whether this watch-and-wait approach is safe and effective for patients like you.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Canada